title: Response to letter: "Does Ivabradine really limit dobutamine-induced tachycardia in stable heart failure patients: parallax in significance".
authors.affiliation: APHP-Henri Mondor University Hospital, Cardiovascular Department, Team 3, Creteil, France; INSERM U955, Team 3, Creteil, France. Electronic address: romain.gallet@yahoo.fr.
authors.forename: Romain
authors.initials: R
authors.lastname: Gallet
authors.affiliation: APHP-Henri Mondor University Hospital, Cardiovascular Department, Team 3, Creteil, France; INSERM U955, Team 3, Creteil, France.
authors.forename: Julien
authors.initials: J
authors.lastname: Ternacle
authors.affiliation: APHP-Henri Mondor University Hospital, Cardiovascular Department, Team 3, Creteil, France; INSERM U955, Team 3, Creteil, France.
authors.forename: Pascal
authors.initials: P
authors.lastname: Lim
mesh_terms: D001552:Benzazepines / Q000008:administration & dosage*; D004280:Dobutamine / Q000008:administration & dosage*; D005260:Female; D054143:Heart Failure, Systolic / Q000175:diagnosis* / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008297:Male; D012720:Severity of Illness Index
chemical_list: D001552:Benzazepines; D004280:Dobutamine
keywords: Cardiogenic shock; Dobutamine; Heart failure; Ivabradine